SEIE - ETF AI Analysis

Top Page

SEI Select International Equity ETF (SEIE)

Rating:63Neutral

Price Target:―

SEIE, the SEI Select International Equity ETF, has a solid overall rating, mainly driven by strong global companies like HSBC, Novartis, and AstraZeneca, which show healthy financial performance, positive earnings calls, and supportive technical trends. Additional support comes from holdings such as GlaxoSmithKline, Murata Manufacturing, and ASML, whose growth and balance sheet strength help the fund, although high valuations and some cash flow or operational challenges in names like Murata, ASML, and ING Groep introduce risk. The main risk factor is that several key holdings appear expensive or near overbought levels, which could make the ETF more sensitive to market pullbacks.

Positive Factors

Strong Recent Performance

The ETF has shown solid gains so far this year and over the past month, indicating positive recent momentum.

Leading Global Companies in Top Holdings

Several of the largest positions, including major financial, health care, and technology names, have delivered strong year-to-date results that support the fund’s overall performance.

Broad International Diversification

Holdings spread across many developed markets such as Japan, the UK, and several European countries help reduce reliance on any single economy.

Negative Factors

Moderately High Expense Ratio

The fund’s fee level is on the higher side for an ETF, which can gradually reduce net returns for long-term investors.

Financial Sector Sensitivity

Meaningful exposure to financial stocks, including some lagging bank holdings, can make the ETF more vulnerable if that sector weakens.

Limited U.S. Market Exposure

With only a small portion invested in U.S. companies, the fund may miss out when the U.S. market outperforms other regions.

SEIE vs. SPDR S&P 500 ETF (SPY)

AUM1.02B

RegionDeveloped Markets

Expense Ratio0.50%

Beta0.74

IssuerSEI

Inception DateOct 10, 2024

Dividend YieldN/A

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume106,408

30 Day Avg. Volume115,292

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

38.19

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering331

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

SEIE Summary

The SEI Select International Equity ETF (SEIE) is a global stock fund that invests in companies outside the U.S., without tracking a specific index. It spreads money across many countries like Japan, the UK, France, and Germany, and across sectors such as financials, industrials, and health care. Well-known holdings include HSBC, Novartis, ASML, and AstraZeneca. An investor might choose SEIE to diversify beyond U.S. stocks and seek long-term growth from international markets. However, the fund’s value can go up and down with global stock markets and changes in foreign economies and currencies.

How much will it cost me?The SEI Select International Equity ETF (SEIE) has an expense ratio of 0.5%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than average because it is actively managed, which typically involves more research and decision-making compared to passively managed funds that track an index.

What would affect this ETF?The SEI Select International Equity ETF (SEIE) could benefit from positive trends in developed markets outside the U.S., such as economic growth or technological advancements, particularly in sectors like financials and healthcare, which have significant weight in the fund. However, challenges like rising interest rates, geopolitical tensions, or regulatory changes in key regions could negatively impact its performance, especially for top holdings like HSBC and Novartis. Diversification across sectors and countries helps mitigate some risks but does not eliminate exposure to global economic uncertainties.

SEIE Top 10 Holdings

SEIE leans heavily on big international banks and health care giants, with HSBC and ING helping to power recent gains as financials stay in the market’s good graces. On the tech side, ASML and Japan’s Murata are rising standouts, giving the fund a nice tailwind from the semiconductor supply chain. Drugmakers like GSK, Novartis, and AstraZeneca are steady anchors rather than thrill-seekers. Not everything is firing, though: U.K. lenders Barclays and Standard Chartered have been more mixed, occasionally putting a drag on this developed-markets, ex-U.S. lineup.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
HSBA	HSBC Holdings	1.97%	$19.51M	£226.99B	58.35%	80 Outperform
6981	Murata Manufacturing Co	1.50%	$14.83M	¥9.10T	111.04%	77 Outperform
GSK	GlaxoSmithKline	1.32%	$13.07M	£80.64B	43.08%	77 Outperform
ASML	ASML Holding NV	1.22%	$12.03M	€477.33B	106.32%	76 Outperform
NOVN	Novartis AG	1.20%	$11.84M	CHF207.57B	22.14%	80 Outperform
INGA	ING GROEP	1.10%	$10.90M	€67.59B	40.19%	61 Neutral
AZN	AstraZeneca	1.03%	$10.15M	$292.69B	32.74%	80 Outperform
	―	0.99%	$9.77M	―	―	―
ENR	Siemens Energy	0.98%	$9.71M	€159.84B	171.79%	72 Outperform
BARC	Barclays	0.95%	$9.42M	£57.95B	44.83%	78 Outperform

SEIE Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

33.62

Positive

100DMA

33.33

Positive

200DMA

31.64

Positive

Market Momentum

MACD

0.21

Positive

RSI

48.39

Neutral

STOCH

16.80

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SEIE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 34.08, equal to the 50-day MA of 33.62, and equal to the 200-day MA of 31.64, indicating a neutral trend. The MACD of 0.21 indicates Positive momentum. The RSI at 48.39 is Neutral, neither overbought nor oversold. The STOCH value of 16.80 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SEIE.

SEIE Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
SEIE	―	―	$1.02B	0.50%	63 Neutral
FYLD	―	―	$621.51M	0.59%	60 Neutral
TXUE	―	―	$438.43M	0.65%	63 Neutral
AVSD	―	―	$437.25M	0.23%	65 Neutral
RFDI	―	―	$150.29M	0.83%	68 Neutral
DXIV	―	―	$147.67M	0.30%	62 Neutral

Performance Comparison

SEIE

SEI Select International Equity ETF

33.70

7.34

27.85%

FYLD

Cambria Foreign Shareholder Yield ETF

―

TXUE

Thornburg International Equity ETF

―

AVSD

Avantis Responsible International Equity ETF

―

RFDI

First Trust Riverfront Dynamic Developed International ETF

―

DXIV

Dimensional International Vector Equity ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents